Citations (51)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Valentino Laquintana, Adriana Trapani, Nunzio Denora, Fan Wang, James M Gallo & Giuseppe Trapani. (2009) New strategies to deliver anticancer drugs to brain tumors. Expert Opinion on Drug Delivery 6:10, pages 1017-1032.
Read now
Read now
Enrico Franceschi, Alicia Tosoni, Stefania Bartolini, Valeria Mazzocchi, Antonio Fioravanti & Alba A Brandes. (2009) Treatment options for recurrent glioblastoma: pitfalls and future trends. Expert Review of Anticancer Therapy 9:5, pages 613-619.
Read now
Read now
Alba A Brandes, Umberto Basso & Lara M Pasetto. (2001) Changing boundaries in the treatment of malignant gliomas. Expert Review of Anticancer Therapy 1:3, pages 357-370.
Read now
Read now
Michele Reni, Cesare Cozzarini, Andrés J. M. Ferreri, Giovanni L. Ceresoli, Laura Galli, Alessandra Bianchi & Eugenio Villa. (2000) A Retrospective Analysis of Postradiation Chemotherapy in 133 Patients with Glioblastoma Multiforme. Cancer Investigation 18:6, pages 510-515.
Read now
Read now
C.
L. Chen, R.
K. Narla, X.
P. Liu & F.
M. Uckun. (1999) A QUANTITATIVE HPLC DETECTION METHOD FOR WHI-P154 [4-(3′-BROMO-4′-HYDROXYLPHENYL)-AMINO-6,7-DIMETHOXYQUINAZOLINE]. Journal of Liquid Chromatography & Related Technologies 22:11, pages 1771-1783.
Read now
Read now
Articles from other publishers (46)
F. Ilknur Kayalı & Rahsan Habiboğlu. (2021) CAN HYPOFRACTIONATED REIRRADIATION PLUS TEMOZOLAMIDE BE A WISE CHOICE FOR RECURRENT HIGH AND LOW GRADE BRAIN TUMORS?. Journal of Radiation Research and Applied Sciences 14:1, pages 229-235.
Crossref
Crossref
Ashwin Venkatesh, Amol Joshi, Kieren Allinson, Tilak Das, Thomas Santarius, Sarah J. Jefferies, Fiona P. Harris, Rajesh Jena & Gary J. Doherty. (2021) Response to BRAF and MEK1/2 inhibition in a young adult with BRAF V600E mutant epithelioid glioblastoma multiforme: A Case Report and Literature Review. Current Problems in Cancer 45:5, pages 100701.
Crossref
Crossref
Fumio Yamaguchi. (2017) Therapy Decisions for Patients with High-Grade Glioma and Their Families. World Neurosurgery 102, pages 671-672.
Crossref
Crossref
Yuan-Yun Tseng, Yin-Chen Huang, Tao-Chieh Yang, Shun-Tai Yang, Shou-Cheng Liu, Tzu-Min Chang, Yi-Chuan Kau & Shih-Jung Liu. (2016) Concurrent Chemotherapy of Malignant Glioma in Rats by Using Multidrug-Loaded Biodegradable Nanofibrous Membranes. Scientific Reports 6:1.
Crossref
Crossref
Nikita G. Alexiades, Brenda Auffinger, Chung Kwon Kim, Tanwir Hasan, Gina Lee, Marc Deheeger, Alex L. Tobias, Janice Kim, Irina Balyasnikova, Maciej S. Lesniak, Karen Aboody & Atique U. Ahmed. (2015) MMP14 as a novel downstream target of VEGFR2 in migratory glioma-tropic neural stem cells. Stem Cell Research 15:3, pages 598-607.
Crossref
Crossref
James O. Galle, Mark W. McDonald, Victor Simoneaux & Jeffrey C. Buchsbaum. (2015) Reirradiation with Proton Therapy for Recurrent Gliomas. International Journal of Particle Therapy 2:1, pages 11-18.
Crossref
Crossref
D Yin, Y Zhai, H E Gruber, C E Ibanez, J M Robbins, A P Kells, N Kasahara, J Forsayeth, D J Jolly & K S Bankiewicz. (2013) Convection-enhanced delivery improves distribution and efficacy of tumor-selective retroviral replicating vectors in a rodent brain tumor model. Cancer Gene Therapy 20:6, pages 336-341.
Crossref
Crossref
Parvinder Hothi, Timothy J. Martins, LiPing Chen, Loic Deleyrolle, Jae-Geun Yoon, Brent Reynolds & Greg Foltz. (2012) High-Throughput Chemical Screens Identify Disulfiram as an Inhibitor of Human Glioblastoma Stem Cells. Oncotarget 3:10, pages 1124-1136.
Crossref
Crossref
Marina Mendiburu-Eliçabe, Dali Yin, Piotr Hadaczek, Yuying Zhai, John Forsayeth & Krystof S. Bankiewicz. (2012) Systemic rapamycin alone may not be a treatment option for malignant glioma: evidence from an in vivo study. Journal of Neuro-Oncology 108:1, pages 53-58.
Crossref
Crossref
Kyle C. Cuneo, James J. Vredenburgh, John H. Sampson, David A. Reardon, Annick Desjardins, Katherine B. Peters, Henry S. Friedman, Christopher G. Willett & John P. Kirkpatrick. (2012) Safety and Efficacy of Stereotactic Radiosurgery and Adjuvant Bevacizumab in Patients With Recurrent Malignant Gliomas. International Journal of Radiation Oncology*Biology*Physics 82:5, pages 2018-2024.
Crossref
Crossref
B. Tyler, S. Wadsworth, V. Recinos, V. Mehta, A. Vellimana, K. Li, J. Rosenblatt, H. Do, G. L. Gallia, I.-M. Siu, R. T. Wicks, M. A. Rudek, M. Zhao & H. Brem. (2011) Local delivery of rapamycin: a toxicity and efficacy study in an experimental malignant glioma model in rats. Neuro-Oncology 13:7, pages 700-709.
Crossref
Crossref
Torok. (2011) Re-irradiation with Radiosurgery for Recurrent Glioblastoma Multiforme. Technology in Cancer Research and Treatment.
Crossref
Crossref
Ernesto Maranzano, Paola Anselmo, Michelina Casale, Fabio Trippa, Sandro Carletti, Massimo Principi, Fabio Loreti, Marco Italiani, Claudia Caserta & Cesare Giorgi. (2018) Treatment of Recurrent Glioblastoma with Stereotactic Radiotherapy: Long-Term Results of a Mono-Institutional Trial. Tumori Journal 97:1, pages 56-61.
Crossref
Crossref
Jun Sunayama, Atsushi Sato, Ken-ichiro Matsuda, Ken Tachibana, Kaori Suzuki, Yoshitaka Narita, Soichiro Shibui, Kaori Sakurada, Takamasa Kayama, Arata Tomiyama & Chifumi Kitanaka. (2010) Dual blocking of mTor and PI3K elicits a prodifferentiation effect on glioblastoma stem-like cells. Neuro-Oncology 12:12, pages 1205-1219.
Crossref
Crossref
. (2010) Abstracts. The Neuroradiology Journal 23:1_suppl, pages 75-370.
Crossref
Crossref
ChunSheng Kang, XuBo Yuan, Yue Zhong, PeiYu Pu, YanShuang Guo, Ammar Albadany, ShiZhu Yu, ZhiYong Zhang, YanHe Li, Jin Chang & Jing Sheng. (2009) Growth Inhibition against Intracranial C6 Glioma Cells by Stereotactic Delivery of BCNU by Controlled Release from poly(D,L-lactic acid) Nanoparticles. Technology in Cancer Research & Treatment 8:1, pages 61-70.
Crossref
Crossref
Keith L. Black, Dali Yin, John M. Ong, Jinwei Hu, Bindu M. Konda, Xiao Wang, MinHee K. Ko, Jennifer-Ann Bayan, Manuel R. Sacapano, Andreas Espinoza, Dwain K. Irvin & Yan Shu. (2008) PDE5 inhibitors enhance tumor permeability and efficacy of chemotherapy in a rat brain tumor model. Brain Research 1230, pages 290-302.
Crossref
Crossref
Stephanie E. Combs, Marc Bischof, Thomas Welzel, Holger Hof, Susanne Oertel, Jürgen Debus & Daniela Schulz-Ertner. (2008) Radiochemotherapy with temozolomide as re-irradiation using high precision fractionated stereotactic radiotherapy (FSRT) in patients with recurrent gliomas. Journal of Neuro-Oncology 89:2, pages 205-210.
Crossref
Crossref
Alba A. Brandes, Alicia Tosoni, Enrico Franceschi, Michele Reni, Gemma Gatta & Charles Vecht. (2008) Glioblastoma in adults. Critical Reviews in Oncology/Hematology 67:2, pages 139-152.
Crossref
Crossref
Dali Yin, Xiao Wang, Bindu M. Konda, John M. Ong, Jinwei Hu, Manuel R. Sacapano, MinHee K. Ko, Andres J. Espinoza, Dwain K. Irvin, Yan Shu & Keith L. Black. (2008) Increase in Brain Tumor Permeability in Glioma-Bearing Rats with Nitric Oxide Donors. Clinical Cancer Research 14:12, pages 4002-4009.
Crossref
Crossref
Klaus Maier-Hauff, Ronny Rothe, Regina Scholz, Uwe Gneveckow, Peter Wust, Burghard Thiesen, Annelie Feussner, Andreas von Deimling, Norbert Waldoefner, Roland Felix & Andreas Jordan. (2006) Intracranial Thermotherapy using Magnetic Nanoparticles Combined with External Beam Radiotherapy: Results of a Feasibility Study on Patients with Glioblastoma Multiforme. Journal of Neuro-Oncology 81:1, pages 53-60.
Crossref
Crossref
Andreas Jordan & Klaus Maier-Hauff. 2007. Regional Cancer Therapy. Regional Cancer Therapy
379
393
.
Herbert B. Newton. 2006. Handbook of Brain Tumor Chemotherapy. Handbook of Brain Tumor Chemotherapy
347
363
.
Stephanie E. CombsChristoph ThilmannLutz EdlerJürgen DebusDaniela Schulz-Ertner. (2005) Efficacy of Fractionated Stereotactic Reirradiation in Recurrent Gliomas: Long-Term Results in 172 Patients Treated in a Single Institution. Journal of Clinical Oncology 23:34, pages 8863-8869.
Crossref
Crossref
Stephanie E. Combs, Verena Widmer, Christoph Thilmann, Holger Hof, Juergen Debus & Daniela Schulz‐Ertner. (2005) Stereotactic radiosurgery (SRS). Cancer 104:10, pages 2168-2173.
Crossref
Crossref
Ho-Shin Gwak, Sang-Min Youn, Austin-Hyuk Kwon, Seung Hoon Lee, Jong Hyun Kim & Chang Hun Rhee. (2005) ACNU–cisplatin Continuous Infusion Chemotherapy as Salvage Therapy for Recurrent Glioblastomas: Phase II Study. Journal of Neuro-Oncology 75:2, pages 173-180.
Crossref
Crossref
Evanthia Galanis, Jan C. Buckner, Matthew J. Maurer, Joel M. Reid, Mary J. Kuffel, Matthew M. Ames, Bernd W. Scheithauer, Julie E. Hammack, George Pipoly & Steven A. Kuross. (2005) Phase I/II trial of pyrazoloacridine and carboplatin in patients with recurrent glioma: A North Central Cancer Treatment Group trial. Investigational New Drugs 23:5, pages 495-503.
Crossref
Crossref
Renato LaRocca, Shawn Glisson, Jeffrey Hargis, David Petruska, Wayne Villanueva, Dante Morassutti, Dale Horne & Falguni Amin-Zimmerman. (2005) High-Grade Glioma Treated With Surgery; Carmustine Wafer; Postoperative Radiation; and Procarbazine, Lomustine, and Vincristine Chemotherapy. Neurosurgery Quarterly 15:3, pages 167-171.
Crossref
Crossref
G. Pöpperl, R. Goldbrunner, F. J. Gildehaus, F. W. Kreth, P. Tanner, M. Holtmannspötter, J. C. Tonn & K. Tatsch. (2005) O-(2-[18F]fluoroethyl)-l-tyrosine PET for monitoring the effects of convection-enhanced delivery of paclitaxel in patients with recurrent glioblastoma. European Journal of Nuclear Medicine and Molecular Imaging 32:9, pages 1018-1025.
Crossref
Crossref
Evanthia GalanisJan C. BucknerMatthew J. MaurerJeffrey I. KreisbergKarla BallmanJ. BoniJosep M. PeralbaRobert B. JenkinsShaker R. DakhilRoscoe F. MortonKurt A. JaeckleBernd W. ScheithauerJanet DanceyManuel HidalgoDaniel J. Walsh. (2005) Phase II Trial of Temsirolimus (CCI-779) in Recurrent Glioblastoma Multiforme: A North Central Cancer Treatment Group Study. Journal of Clinical Oncology 23:23, pages 5294-5304.
Crossref
Crossref
G. Noël, Chiraz N. Ben Ammar, L. Feuvret, C.-A. Valery, P. Cornu, G. Boisserie, J.-M. Simon, D. Hasboun, B. Tep, J.-Y. Delattre, M. Sanson, F. Baillet & J.-J. Mazeron. (2004) Résultats de l’irradiation en conditions stéréotaxiques de rattrapage de 14 patients atteints d’un gliome de grade III ou IV. Revue Neurologique 160:5, pages 539-545.
Crossref
Crossref
Peter Hau, Klaus Fabel, Ulrike Baumgart, Petra Rümmele, Oliver Grauer, Annekatrin Bock, Christopher Dietmaier, Wolfgang Dietmaier, Jörg Dietrich, Christine Dudel, Franz Hübner, Tanya Jauch, Elisabeth Drechsel, Ingo Kleiter, Cäcile Wismeth, Anton Zellner, Alexander Brawanski, Andreas Steinbrecher, Jörg Marienhagen & Ulrich Bogdahn. (2004) Pegylated liposomal doxorubicin‐efficacy in patients with recurrent high‐grade glioma. Cancer 100:6, pages 1199-1207.
Crossref
Crossref
Peter Hau, Ulrike Baumgart, Katharina Pfeifer, Anne Bock, Tanya Jauch, Jörg Dietrich, Klaus Fabel, Oliver Grauer, Caecilia Wismeth, Monika Klinkhammer‐Schalke, Michael Allgäuer, Gerhard Schuierer, Horst Koch, Juergen Schlaier, Winfried Ulrich, Alexander Brawanski, Ulrich Bogdahn & Andreas Steinbrecher. (2003) Salvage therapy in patients with glioblastoma. Cancer 98:12, pages 2678-2686.
Crossref
Crossref
C. Miyamoto. 2003. Combined Modality Therapy of Central Nervous System Tumors. Combined Modality Therapy of Central Nervous System Tumors
345
363
.
Klaus Fabel, J�rg Dietrich, Peter Hau, Caecilie Wismeth, Beate Winner, Saskia Przywara, Andreas Steinbrecher, Winfried Ullrich & Ulrich Bogdahn. (2001) Long-term stabilization in patients with malignant glioma after treatment with liposomal doxorubicin. Cancer 92:7, pages 1936-1942.
Crossref
Crossref
A.A. Brandes, M. Ermani, U. Basso, P. Amistà, F. Berti, R. Scienza, A. Rotilio, G. Pinna, M. Gardiman & S. Monfardini. (2001) Temozolomide as a second-line systemic regimen in recurrent high-grade glioma: A phase II study. Annals of Oncology 12:2, pages 255-258.
Crossref
Crossref
Mark T. Jennings & Sunita Iyengar. (2001) Pharmacotherapy of Malignant Astrocytomas of Children and Adults. CNS Drugs 15:9, pages 719-743.
Crossref
Crossref
Ernest C. Borden, Daniel Lindner, Robert Dreicer, Mohamad Hussein & David Peereboom. (2000) Second-generation interferons for cancer: clinical targets. Seminars in Cancer Biology 10:2, pages 125-144.
Crossref
Crossref
Jane Chandramouli, Linda S Tyler & Jennifer M. Hoffman. (2017) This CE is published through an unrestricted educational grant from Bristol-Myers Squibb. Hospital Pharmacy 35:3, pages 257-272.
Crossref
Crossref
Jeffrey N. Bruce, Asdrubal Falavigna, Jeffrey P. Johnson, Jonathan S. Hall, Barry D. Birch, Jung T. Yoon, Edward X. Wu, Robert L. Fine & Andrew T. Parsa. (2000) Intracerebral Clysis in a Rat Glioma Model. Neurosurgery 46:3, pages 683-691.
Crossref
Crossref
Kwan H Cho, Walter A Hall, Bruce J Gerbi, Patrick D Higgins, Warren A McGuire & H.Brent Clark. (1999) Single dose versus fractionated stereotactic radiotherapy for recurrent high-grade gliomas. International Journal of Radiation Oncology*Biology*Physics 45:5, pages 1133-1141.
Crossref
Crossref
Kerrie ClarkeRussell L. BasserCraig UnderhillPeter MitchellJane BartlettLawrence CherMichael FindlayDavid DalleyMalcolm PellMichael ByrneHoward GeldardJohn S. HillDarryl MaherRichard M. FoxMichael D. GreenAndrew H. Kaye. (1999) KRN8602 (MX2-Hydrochloride): An Active New Agent for the Treatment of Recurrent High-Grade Glioma. Journal of Clinical Oncology 17:8, pages 2579-2579.
Crossref
Crossref
A Biroccio, D Del Bufalo, A Ricca, C D’Angelo, G D’Orazi, A Sacchi, S Soddu & G Zupi. (1999) Increase of BCNU sensitivity by wt-p53 gene therapy in glioblastoma lines depends on the administration schedule. Gene Therapy 6:6, pages 1064-1072.
Crossref
Crossref
Henry S. FriedmanWilliam P. PetrosAllan H. FriedmanLarry J. SchaafTracy KerbyJennifer LawyerMary ParryPeter J. HoughtonShelley LovellKarima RasheedTim CloughseyElizabeth S. StewartO. Michael ColvinJames M. ProvenzaleRoger E. McLendonDarell D. BignerIlkcan CokgorMichael HaglundJeremy RichDavid AshleyJoseph MalczynGary L. ElfringLangdon L. Miller. (1999) Irinotecan Therapy in Adults With Recurrent or Progressive Malignant Glioma. Journal of Clinical Oncology 17:5, pages 1516-1516.
Crossref
Crossref
Alba A. BrandesMario ErmaniSergio TurazziElvira ScelziFranco BertiPietro AmistàAntonino RotilioClaudio LicataMario V. Fiorentino. (1999) Procarbazine and High-Dose Tamoxifen as a Second-Line Regimen in Recurrent High-Grade Gliomas: A Phase II Study. Journal of Clinical Oncology 17:2, pages 645-645.
Crossref
Crossref
Gilbert Lederman, Ehud Arbit, Marcel Odaimi, Elizabeth Lombardi, Monika Wrzolek & Marek Wronski. (1998) Fractionated stereotactic radiosurgery and concurrent taxol in recurrent glioblastoma multiforme: A preliminary report. International Journal of Radiation Oncology*Biology*Physics 40:3, pages 661-666.
Crossref
Crossref